11-2445439-T-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000218.3(KCNQ1):c.341T>C(p.Leu114Pro) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
KCNQ1
NM_000218.3 missense
NM_000218.3 missense
Scores
12
5
2
Clinical Significance
Conservation
PhyloP100: 7.03
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.969
PP5
Variant 11-2445439-T-C is Pathogenic according to our data. Variant chr11-2445439-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 53036.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2445439-T-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.341T>C | p.Leu114Pro | missense_variant | 1/16 | ENST00000155840.12 | NP_000209.2 | |
KCNQ1 | NM_001406836.1 | c.341T>C | p.Leu114Pro | missense_variant | 1/15 | NP_001393765.1 | ||
KCNQ1 | NM_001406838.1 | c.341T>C | p.Leu114Pro | missense_variant | 1/11 | NP_001393767.1 | ||
KCNQ1 | NM_001406837.1 | c.-22T>C | 5_prime_UTR_variant | 1/17 | NP_001393766.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.341T>C | p.Leu114Pro | missense_variant | 1/16 | 1 | NM_000218.3 | ENSP00000155840.2 | ||
KCNQ1 | ENST00000345015.4 | n.118T>C | non_coding_transcript_exon_variant | 1/3 | 1 | |||||
KCNQ1 | ENST00000496887.7 | c.80T>C | p.Leu27Pro | missense_variant | 2/16 | 5 | ENSP00000434560.2 | |||
KCNQ1 | ENST00000646564.2 | c.341T>C | p.Leu114Pro | missense_variant | 1/11 | ENSP00000495806.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Long QT syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 25, 2022 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 17053194, 19114714, 19841300, 25348405). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 53036). This missense change has been observed in individuals with long QT syndrome (PMID: 12402336). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 114 of the KCNQ1 protein (p.Leu114Pro). - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 18, 2017 | The p.L114P variant (also known as c.341T>C), located in coding exon 1 of the KCNQ1 gene, results from a T to C substitution at nucleotide position 341. The leucine at codon 114 is replaced by proline, an amino acid with similar properties. This alteration has been reported in a long QT syndrome cohort, but clinical details were limited (Jongbloed R et al. Hum. Mutat. 2002;20:382-91). Functional studies in multiple cell types indicate that this variant causes loss of function as a result of a trafficking defect (Dahimène S et al. Circ. Res. 2006;99:1076-83). Internal structural analysis suggests that this alteration is significantly disruptive in a sensitive region and more disruptive than a nearby known pathogenic variant (Long SB et al. Nature. 2007;450(7168):376-82). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:12402336;PMID:17053194;PMID:19114714). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
.;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Benign
.;L
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
1.0
.;D
Vest4
0.98
MutPred
0.85
.;Gain of catalytic residue at N112 (P = 0.0576);
MVP
MPC
2.8
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at